VANTE TO DEMONSTRATE SOON TO BE AVAILABLE SAFFIRE® II AT MD&M WEST
New Device Allows Programming to be Stored on Mold Module,Contributes to Easier Validation Process
Anaheim, CA, February 7th, 2011 – Medical device manufacturing equipment leader Vante will be demonstrating their soon to be available SAFFIRE® II this week at medical device conference MD&M West in Anaheim, CA. The Vante SAFFIRE® System, utilizing precision energy control and heat placement, is designed for catheter manufacturing.
Located at Booth #2413, Vante has free passes to MD&M West, which can be obtained by contacting Mark Miller of Vante at Mmiller@vante.com or 520.545.0665. Vante will also be raffling off an iPad at their booth.
“Vante’s soon to be available SAFFIRE® II has major new features including a ‘Hot Swappable Auto Configuring Smart Mold’,” stated Brent Fausett: Executive Vice President. “It also features digital pressure regulation and effortless tooling change. These advances allow for ease of programming and a final product that is easier to validate. We are excited to be offering the SAFFIRE® II to companies around the globe and urge them to contact us and learn more about the SAFFIRE® II, and how Vante can provide solutions to their applications.”
The Vante SAFFIRE® System generator features a large color touch screen allowing the operator to view operating cycle parameters and temperature feedback. New proprietary inductive heating technology also allows for much higher temperatures while significantly extending the life of the heater. The Vante SAFFIRE system consists of a model 4200 RF generator and one of two forming platforms, depending on insertion force requirements. All platforms can be teamed with a variety of tipping, welding, and forming molds for many different applications.
“Vante is an employee-owned, global technology company that designs and produces best of breed products for the precise manipulation of medical plastics,” stated Roger Vogel, Vante Chairman, President and CEO. “Our company is focused on catheter development and manufacturing, bio-pharmaceutical products, and related engineering services.”